The approach to lymphaticovenular anastomosis (LVA) for breast cancer treatment-related lymphedema should differ from that performed for secondary lower extremity lymphedema (LEL) because upper extremity lymphedema (UEL) and LEL differ in terms of the areas affected, imaging features, and postoperative improvements.
Τρίτη 13 Φεβρουαρίου 2018
Lymphaticovenular anastomosis for breast cancer treatment-related lymphedema: three-line strategy for an optimal outcome
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.